Methodology

All entries for: Deepcure Inc.

July 9, 2025

Deepcure Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of nuclear protein in testis (NUT) carcinoma

Disease Area: Rare Diseases
Source
Source
Scroll to Top